Biomarker profile for the diagnosis of Creutzfeldt–Jakob disease

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Geissen M et al. (2007) Understanding the natural variability of prion diseases. Vaccine 25: 5631–5636

  2. 2

    Hsich G et al. (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335: 924–930

  3. 3

    Collins SJ et al. (2006) Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt–Jakob disease. Brain 129: 2278–2287

  4. 4

    Fagan AM et al. (2007) Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol 64: 343–349

Download references


The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Glatzel, M. Biomarker profile for the diagnosis of Creutzfeldt–Jakob disease. Nat Rev Neurol 4, 70–71 (2008).

Download citation